Govt Seeks More Data For Full Market Clearance To Covishield, Covaxin

New Delhi: Approval for full market authorisation for both Covid-19 vaccines, Covishield and Covaxin, could take longer, with the subject expert committee of the national drugs regulator seeking more data from the manufacturers in its meeting on Friday. Serum Institute of India (SII) and Bharat Biotech International Ltd, manufacturers of Covishield and Covaxin respectively, separately applied to the central drugs standard control organisation (CDSCO) to seek full market authorisation stating that more than a billion vaccine doses have been administered to beneficiaries under the national Covid-19 immunisation programme.